Wong, Risa L. http://orcid.org/0000-0003-1658-9465
Yu, Evan Y.
Article History
Accepted: 20 December 2020
First Online: 12 January 2021
Compliance with Ethical Standards
:
: Evan Y. Yu has received research funding from Bayer, Dendreon, Merck, Pharmacyclics, Seattle Genetics, Daiichi Sankyo, Taiho Pharmaceutical, and Blue Earth Diagnostics, Inc.; and has received compensation for service as a consultant from Amgen, AstraZeneca, Bayer, Clovis Oncology, Dendreon, Janssen, Merck, Pharmacyclics, Seattle Genetics, Advanced Accelerator Applications, Sanofi, AbbVie, Incyte Corporation, and QED Therapeutics. Risa L. Wong declares that she has no conflict of interest.